Cell-mediated and Neutralizing Antibody Responses to the SARS-CoV-2 Omicron BA.4/BA.5-adapted Bivalent Vaccine Booster in Kidney and Liver Transplant Recipients.

Mario Fernández-RuizPatricia Almendro-VázquezNatalia RedondoTamara Ruiz-MerloSandra AbellaAdán SomozaFrancisco López-MedranoRafael San JuanCarmelo LoinazAmado AndrésEstela Paz-ArtalJosé María Aguado

Published in: Transplantation direct (2023)

Booster with the BA.4/BA.5-adapted bivalent vaccine generated strong subvariant-specific responses among SOT recipients. Booster-induced cell-mediated immunity, however, remained lower than in immunocompetent individuals.

Keyphrases

sars cov
single cell
cell therapy
stem cells
high glucose
oxidative stress
dengue virus
respiratory syndrome coronavirus
drug induced
coronavirus disease
kidney transplantation
stress induced
aedes aegypti